Immunogenicity and Safety of Pentaxim™ in an Indian Population

Clinical trial NCT00259337 · COMPLETED

Trial details

NCT number: NCT00259337
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Polio Pertussis Haemophilus Infections

Start date: 2006-02-01
Primary completion: 2008-04-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.